NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/11/2018
Back to search
Official data from USPTO
CONATUS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONATUS PHARMACEUTICALS
ST13
US500000078681953Class
5
Filing
78681953
Registration
3525730
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
04/11/2018
Trademark type
Word
Nice classes
5
Filing date
07/29/2005
Registration date
10/28/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2018
Last transaction
04/11/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/10/2008
First use in commerce
07/10/2008
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
REIHNER, DAVID
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Conatus Pharmaceuticals, Inc.
Representatives
Perry J. Viscounty LATHAM & WATKINS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF ACUTE AND CHRONIC DISEASE RESULTING FROM ABNORMAL INFLAMMATION
Publications
History of USPTO decisions and trademark events.
51 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/11/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/11/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/11/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
03/28/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/28/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/10/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/10/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/10/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/02/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/02/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2014
ES8R
TEAS SECTION 8 RECEIVED
08/29/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/23/2008
ALIE
ASSIGNED TO LIE
09/23/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/15/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/10/2008
EX4G
SOU EXTENSION 4 GRANTED
09/10/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/10/2008
IUAF
USE AMENDMENT FILED
09/03/2008
EXT4
SOU EXTENSION 4 FILED
09/03/2008
EEXT
SOU TEAS EXTENSION RECEIVED
09/03/2008
EISU
TEAS STATEMENT OF USE RECEIVED
09/03/2008
EX3G
SOU EXTENSION 3 GRANTED
02/26/2008
EXT3
SOU EXTENSION 3 FILED
02/26/2008
EEXT
SOU TEAS EXTENSION RECEIVED
02/26/2008
EX2G
SOU EXTENSION 2 GRANTED
09/21/2007
EXT2
SOU EXTENSION 2 FILED
08/28/2007
EEXT
SOU TEAS EXTENSION RECEIVED
08/28/2007
EX1G
SOU EXTENSION 1 GRANTED
05/29/2007
EXT1
SOU EXTENSION 1 FILED
02/28/2007
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/05/2006
PUBO
PUBLISHED FOR OPPOSITION
06/13/2006
NPUB
NOTICE OF PUBLICATION
05/24/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/21/2006
ALIE
ASSIGNED TO LIE
04/14/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
04/07/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2006
GNRT
NON-FINAL ACTION E-MAILED
04/04/2006
CNRT
NON-FINAL ACTION WRITTEN
04/04/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2006
GNRT
NON-FINAL ACTION E-MAILED
02/16/2006
CNRT
NON-FINAL ACTION WRITTEN
02/16/2006
DOCK
ASSIGNED TO EXAMINER
02/16/2006
NWAP
NEW APPLICATION ENTERED
08/05/2005
Continuous trademark protection
Get notified about every new filing that threatens CONATUS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.